 | Up a level |
Perez, K, Cleary, J. M., Karasic, T. B., Raghaven, S., Rahma, O. E., Nowak, J. A., Borazanci, E. H., Downes, Michael, Drebin, Jeffrey A, Tuveson, D. A., Ting, D. T., Moffitt, R. A., Yeh, J. J., Aguirre, A. J., Evans, R., Von Hoff, D. D., Odwyer, P. J., Wolpin, B. M. (February 2020) Vitamin D receptor agonist paricalcitol plus gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer. Journal of Clinical Oncology, 38 (4). ISSN 0732-183X
Sherman, Mara H, Yu, Ruth T, Engle, Dannielle D, Ding, Ning, Atkins, Annette R, Tiriac, Herve, Collisson, Eric A, Connor, Frances, Van Dyke, Terry, Kozlov, Serguei, Martin, Philip, Tseng, Tiffany W, Dawson, David W, Donahue, Timothy R, Masamune, Atsushi, Shimosegawa, Tooru, Apte, Minoti V, Wilson, Jeremy S, Ng, Beverly, Lau, Sue Lynn, Gunton, Jenny E, Wahl, Geoffrey M, Hunter, Tony, Drebin, Jeffrey A, O’Dwyer, Peter J, Liddle, Christopher, Tuveson, David A, Downes, Michael, Evans, Ronald M (September 2014) Vitamin D Receptor-Mediated Stromal Reprogramming Suppresses Pancreatitis and Enhances Pancreatic Cancer Therapy. Cell, 159 (1). pp. 80-93. ISSN 0092-8674
